95TiP Gruppo Italiano Mammella (GIM) 10 – CONSENT: A phase III randomized study comparing concurrent versus sequential administration of adjuvant chemotherapy (CT) and aromatase inhibitors (AIs) in post-menopausal patients (pts) with hormone receptor-positive (HR+) early breast cancer (EBC)
Title:
95TiP Gruppo Italiano Mammella (GIM) 10 – CONSENT: A phase III randomized study comparing concurrent versus sequential administration of adjuvant chemotherapy (CT) and aromatase inhibitors (AIs) in post-menopausal patients (pts) with hormone receptor-positive (HR+) early breast cancer (EBC)
Author:
Lambertini, M. Guarneri, V. Caremoli, E.R. Rocca, A. Montemurro, F. De Laurentiis, M. Giordano, M. De Placido, S. Bisagni, G. Garrone, O. Ferzi, A. Giovanardi, F. Cognetti, F. Amaducci, L. Bernardo, A. Livi, L. Bighin, C. Poggio, F. Ballestrero, A. Del Mastro, L.